StreetAlpha
Anaptysbio, Inc · SEC Form 4

ANAB Insider Trading

From SEC Form 431 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Anaptysbio, Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net buyers over the last 12 months: $17.2M bought and $9.8M sold.

← ANAB stock page

Insiders are net buyers
Bought, 12 months$17.2M1 buys · 1 insiders
Sold, 12 months$9.8M23 sales · 8 insiders
Net+$7.5Mbought minus sold
Planned sales37%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $3MDec2026-01: sold $3.7MJan2026-02: sold $540KFeb2026-03: sold $2.2MMarAprMayJunJulAugSep2026-10: sold $249KOct2026-11: bought $17.2MNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when ANAB insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an ANAB officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every ANAB insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 18, 2026EcoR1 Capital, LLCDirectorBuy374,580$45.98$17.2M8,254,674Nov 18Form 4
Oct 1, 2026Hollings RentonDirectorSale plan5,000$49.87$249K10,995Oct 2Form 4
Mar 30, 2026John P. SchmidDirectorSale20,645$56.11$1.2M31,622Apr 1Form 4
Mar 27, 2026Daniel FagaPresident, CEOSale17,679$61.61$1.1M495,965Mar 27Form 4
Feb 11, 2026Eric J LoumeauChief Legal OfficerSale plan10,000$54.00$540K12,835Feb 13Form 4
Jan 15, 2026Magda MarquetDirectorSale11,000$48.23$531K9,930Jan 16Form 4
Jan 8, 2026Eric J LoumeauChief Legal OfficerSale2,210$44.71$99K12,835Jan 9Form 4
Jan 8, 2026Dennis MulroyCFOSale2,515$44.71$112K21,852Jan 9Form 4
Jan 8, 2026Daniel FagaPresident, CEOSale14,281$44.71$639K479,344Jan 9Form 4
Jan 8, 2026Paul F. LizzulChief Medical OfficerSale3,650$44.71$163K42,088Jan 9Form 4
Jan 7, 2026Eric J LoumeauChief Legal OfficerSale9,639$45.56$439K9,157Jan 8Form 4
Jan 7, 2026Dennis MulroyCFOSale1,908$45.11$86K17,667Jan 8Form 4
Jan 7, 2026Daniel FagaPresident, CEOSale9,202$45.11$415K466,787Jan 8Form 4
Jan 7, 2026Paul F. LizzulChief Medical OfficerSale2,235$45.11$101K37,213Jan 8Form 4
Jan 5, 2026Eric J LoumeauChief Legal OfficerSale2,983$43.26$129K13,251Jan 6Form 4
🔒 16 more trades. Create a free account or sign in to see them all.

ANAB insider trading FAQ

Are ANAB insiders buying or selling?

Insiders are net buyers over the last 12 months. 1 insiders bought $17.2M of ANAB on the open market in 1 trades, and 8 sold $9.8M in 23 trades, 37% of that under pre-arranged trading plans.

When did an ANAB insider last buy shares?

EcoR1 Capital, LLC (Director) bought 374,580 shares for $17.2M on Nov 18, 2026, reported on Nov 18, 2026.

When did an ANAB insider last sell shares?

Hollings Renton (Director) sold 5,000 shares for $249K on Oct 1, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice